Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:5157730rdf:typepubmed:Citationlld:pubmed
pubmed-article:5157730lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:5157730lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:5157730lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:5157730pubmed:issue3lld:pubmed
pubmed-article:5157730pubmed:dateCreated1972-4-19lld:pubmed
pubmed-article:5157730pubmed:abstractText1. The pharmacokinetics of cyclophosphamide were investigated in cancer patients. The data can be characterized by a two-compartment open model. The half life of the elimination phase of the drug ranged between 3 and 11 hours.2. Extensive tubular reabsorption of the drug resulted in the excretion of only a small percentage of the administered dose. The mean renal clearance was 10.7 ml/minute.3. The calculated fraction of the dose of drug which was metabolized averaged 88%.lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:languageenglld:pubmed
pubmed-article:5157730pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:citationSubsetIMlld:pubmed
pubmed-article:5157730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5157730pubmed:statusMEDLINElld:pubmed
pubmed-article:5157730pubmed:monthNovlld:pubmed
pubmed-article:5157730pubmed:issn0007-1188lld:pubmed
pubmed-article:5157730pubmed:authorpubmed-author:JuskoW JWJlld:pubmed
pubmed-article:5157730pubmed:authorpubmed-author:CohenJ LJLlld:pubmed
pubmed-article:5157730pubmed:authorpubmed-author:DayP WPWlld:pubmed
pubmed-article:5157730pubmed:issnTypePrintlld:pubmed
pubmed-article:5157730pubmed:volume43lld:pubmed
pubmed-article:5157730pubmed:ownerNLMlld:pubmed
pubmed-article:5157730pubmed:authorsCompleteYlld:pubmed
pubmed-article:5157730pubmed:pagination677-80lld:pubmed
pubmed-article:5157730pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:meshHeadingpubmed-meshheading:5157730-...lld:pubmed
pubmed-article:5157730pubmed:year1971lld:pubmed
pubmed-article:5157730pubmed:articleTitlePharmacokinetics of cyclophosphamide in man.lld:pubmed
pubmed-article:5157730pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:5157730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:5157730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:5157730lld:pubmed